Adult human RPE for transplantation: renewing an old promise

Article English OPEN
Blenkinsop, Timothy A. (2015)
  • Publisher: Advances in Regenerative Biology
  • Journal: Advances in Regenerative Biology (issn: 2001-8517, eissn: 2001-8517)
  • Related identifiers: doi: 10.3402/arb.v2.27144
  • Subject: adult stem cell;retinal pigment epithelium; cell transplantation; eye disease
    mesheuropmc: eye diseases | sense organs

Considering the incidence of retinal pigment epithelium (RPE)-related blinding disease will grow to 200 million globally by 2020, the impact of restoring vision by successfully replacing failing or dying RPE is great. In spite of fervent efforts to use primary RPE as a source for transplantation for over 30 years, a clinical therapy has yet to be developed. Due to the progress of pluripotent stem cell technologies and development of RPE differentiation protocols, primary human RPE culture has largely been set aside as a source of RPE for transplantation, as human embryonic stem cell (hESC)- and induced pluripotent stem cell (hiPSC)-derived RPE have become the current popular source for transplantation. Recently, a series of seminal advances in human primary RPE culture has renewed an interest in their potential as a source for RPE transplantation. Primary RPE are better studied and understood than hESC/hiPSC-derived RPE, have an inherent lower risk of tumor formation, and can be Major Histocompatibility Complex (MHC) donor-matched, making them valuable candidates alongside pluripotent stem cells as sources for cell transplantation therapy for RPE-related eye diseases.Keywords: adult stem cell; retinal pigment epithelium; cell transplantation; eye disease(Published: 7 April 2015)Citation: Advances in Regenerative Biology 2015, 2: 27144 -
  • References (43)
    43 references, page 1 of 5

    1. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005; 85: 845 81.

    2. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014; 2: e106 16.

    3. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. 1993; 231: 635 41.

    4. Seaber JH, Machemer R. Adaptation to monocular torsion after macular translocation. Graefes Arch Clin Exp Ophthalmol. 1997; 235: 76 81.

    5. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002; 109: 1492 8.

    6. Blau O, Blau IW. Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy. Stem Cells Cloning. 2014; 7: 101 8.

    7. Garcia IN. Role of hematopoietic stem cell transplantation in multiple myeloma. Clin Lymphoma Myeloma Leukemia. 2014; 15: 86 91.

    8. Billingham RE, Reynolds J. Transplantation studies on sheets of pure epidermal epithelium and on epidermal cell suspensions. Br J Plast Surg. 1952; 5: 25 36.

    9. Pellegrini G, Traverso CE, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997; 349: 990 3.

    10. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145 7.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark